Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Circulating Activated Protein C in Thrombophilia Carriers

Thijs E van Mens, MD MBA, Joost C.M. Meijers, PhD Professor, Saskia Middeldorp, MD PhD Professor of MDcine

Blood (2016) 128 (22): 4948.

https://doi.org/10.1182/blood.V128.22.4948.4948

Published: 2016

Journal Articles

Towards Restoring Coagulation in Hemophilia By Antibody-Mediated Inhibition of Antithrombin

Peter Boross, PhD, Cafer Yildiz, Kamran Bakhtiari, PhD, Joost C.M. Meijers, Prof, PhD, C. Erik Hack, MD PhD

Blood (2015) 126 (23): 550.

https://doi.org/10.1182/blood.V126.23.550.550

Published: 2015

Journal Articles

High Levels of Protein C Are Determinated by PROCR H3 in a Dutch Family.

Maria Carolina Pintao, MD, Sara Roshani, Marieke C.H. de Visser, MD, PhD, Cris Tieken, Michael W.T. Tanck, PhD, Harry Roger Buller, MD, PhD, Iris M Wichers, Joost C.M. Meijers, PhD, Saskia Middeldorp, MD, PhD, Pieter H. Reitsma, PhD

Blood (2009) 114 (22): 2139.

https://doi.org/10.1182/blood.V114.22.2139.2139

Published: 2009

Journal Articles

Evidence for QTLs Influencing the Endogenous Thrombin Potential (ETP) and Protein C Concentrations in a Dutch Family with Unexplained Thrombophilia.

Michael W.T. Tanck, PhD, Iris M. Wichers, MD, Joost C.M. Meijers, PhD, Harry R. Büller, MD, Pieter H. Reitsma, PhD, Saskia Middeldorp, MD

Blood (2007) 110 (11): 132.

https://doi.org/10.1182/blood.V110.11.132.132

Published: 2007

Journal Articles

Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis

Ton Lisman, Philip G. de Groot, Joost C.M. Meijers, Frits R. Rosendaal

Blood (2005) 105 (3): 1102–1105.

https://doi.org/10.1182/blood-2004-08-3253

Published: 2005

Journal Articles

Reduced Plasma Fibrinolytic Potential Is a Risk Factor for Venous Thrombosis.

Ton Lisman, PhD, Philip G. de Groot, PhD, Jelle Adelmeijer, BSci, Joost C.M. Meijers, PhD, Frits R. Rosendaal, MD, PhD

Blood (2004) 104 (11): 2597.

https://doi.org/10.1182/blood.V104.11.2597.2597

Published: 2004

Journal Articles

Protein C Inhibitor Acts as a Procoagulant by Inhibiting the Thrombomodulin-Induced Activation of Protein C in Human Plasma

Marc G.L.M. Elisen, Peter A.Kr. von dem Borne, Bonno N. Bouma, Joost C.M. Meijers

Blood (1998) 91 (5): 1542–1547.

https://doi.org/10.1182/blood.V91.5.1542

Published: 1998

NARROW

Circulating Activated Protein C in Thrombophilia Carriers

Towards Restoring Coagulation in Hemophilia By Antibody-Mediated Inhibition of Antithrombin

High Levels of Protein C Are Determinated by PROCR H3 in a Dutch Family.

Evidence for QTLs Influencing the Endogenous Thrombin Potential (ETP) and Protein C Concentrations in a Dutch Family with Unexplained Thrombophilia.

Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis

Reduced Plasma Fibrinolytic Potential Is a Risk Factor for Venous Thrombosis.

Protein C Inhibitor Acts as a Procoagulant by Inhibiting the Thrombomodulin-Induced Activation of Protein C in Human Plasma

Email alerts

ASH Publications

American Society of Hematology

Circulating Activated Protein C in Thrombophilia Carriers

Towards Restoring Coagulation in Hemophilia By Antibody-Mediated Inhibition of Antithrombin

High Levels of Protein C Are Determinated by PROCR H3 in a Dutch Family.

Evidence for QTLs Influencing the Endogenous Thrombin Potential (ETP) and Protein C Concentrations in a Dutch Family with Unexplained Thrombophilia.

Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis

Reduced Plasma Fibrinolytic Potential Is a Risk Factor for Venous Thrombosis.

Protein C Inhibitor Acts as a Procoagulant by Inhibiting the Thrombomodulin-Induced Activation of Protein C in Human Plasma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only